19/08/2022
23:47:44
+44 (0) 203 8794 460
Free Membership
Login
Watchlist
Kurse
Charts
Trades
News
Fundamental
Toplisten
Alerts
Portfolio
Orderbuch
Forum
PLUS1
Krypto
Börse & Märkte
Devisen
Rohstoffe
Welt Märkte
Follow Feed
Treten Sie unserer Gemeinschaft von Investoren!
JETZT ANMELDEN
Startseite
Investieren
Aktien
USA
NYSE
Asensus Surgical, Inc.
(ASXC)
Finanzwerte
Börsenkurse
Charts
Orderbuch
Trades
News
Finanzwerte
Historisch
Asensus Surgical Inc. (ASXC) Fundamentals
Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. Its single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.
SHARE INFORMATION
Market Cap
US$ 159.193.476
Shares Outstanding
236.718.923
Float
234.445.436
Percent Float
99,04%
Short Interest
0,00
Short Percent Float
0,0%
Short Interest Ratio
0,00
Short Interest Date
-
Latest Fiscal Dividend Per Share
US$ 0,00
Latest Fiscal Revenue
US$ 8.232.000
Latest Fiscal EPS
US$ -0,28
Latest Fiscal Date
2021-12-31
DIVIDENDS
Dividend (3 Years)
US$ 0,00
Dividend (5 Years)
US$ 0,00
Ex Dividend Date
-
Dividend Rate
US$ 0,00
Dividend Yield
0,0%
Payment Cash
-
HOLDERS
Institutions
219
Institutional Holdings Date
2022-07-31
Institutional Bought Previous 3 Months
501.542
Institutional Holdings Percent
31,9%
Institutional Sold Previous 3 Months
28.223.192
Insider Holdings Date
2022-07-31
Insider Bought Previous 3 Months
1.881.863
Insider Holdings Percent
3,2
Insider Sold Previous 3 Months
50.692
Insider Shares Owned
7.522.997
TRADING INFO
52 Week High
US$ 2,37
52 Week Low
US$ 0,35
52 Week High Change
US$ -67,67
21 Day Moving Average
US$ 0,5596
21 Day Extended Moving Average
US$ 0,586572
50 Day Moving Average
US$ 0,4832
50 Day Extended Moving Average
US$ 0,523902
200 Day Moving Average
US$ 0,765637
200 Day Extended Moving Average
US$ 0,832394
10 Day Average Volume
2.488.593
20 Day Average Volume
1.834.202
30 Day Average Volume
1.619.228
50 Day Average Volume
2.556.620
Alpha
0.020109
Beta
1.5748
Standard Deviation
0.578370
R2
0.018547
7 Day Price Change
US$ 0,0025
7 Day Percent Change
0,37%
21 Day Price Change
US$ 0,2274
21 Day Percent Change
51,09%
30 Day Price Change
US$ 0,2225
30 Day Percent Change
49,44%
Month to Date Price Change
US$ 0,2325
Month to Date Percent Change
52,84%
Quarter to Date Price Change
US$ 0,2744
Quarter to Date Percent Change
68,93%
180 Day Price Change
US$ 0,0025
180 Day Percent Change
0,37%
200 Day Price Change
US$ -0,1824
200 Day Percent Change
-21,34%
Year to Date Price Change
US$ -0,4375
Year to Date Percent Change
-39,41%
Asensus Surgical Inc. (ASXC) Key Ratios
PROFITABILITY
EBIT Margin
-978,9%
EBITDA Margin
-785,8%
Pre-Tax Profit Margin
-1.349,0%
Profit Margin Count
0,0%
Gross Margin
-38,0%
Profit Margin TOT
0,0%
INCOME STATEMENTS
Revenue
US$ 7.107.000
Revenue Per Share
US$ 0,03
Revenue (3 Years)
US$ 0,00
Revenue (5 Years)
US$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book
1,30
Total Debt To Equity
0,00
Int Coverage
-99,50
Current Ratio
11,20
Leverage Ratio
1,10
Quick Ratio
9,90
Long Term Debt To Capital
0,03
VALUATION MEASURES
PE Ratio
-2,30
Enterprise Value
US$ 73.137.462
Price to Sales
22,3995
Price to Free Cash
-3,00
PE High Last 5 Years
-0,30
Price To Book
1,20
Price To Cash Flow
0,00
PE Low Last 5 Years
-1,30
Price to Tangible Book
1,30
MANAGEMENT EFFECTIVENESS
Receivables Turnover
4,80
Invoice Turnover
0,70
Assets Turnover
0,10
Return Assets
-42,25
Return on Equity
-46,47
Return on Capital
-42,12
Asensus Surgical Inc. (ASXC) Profile
PROFILE INFO
Issue Type
CS
SEC Type
EQS
Auditor
BDO USA, LLP
CEO
Anthony C. J. Fernando
Emplyoees
167
Last Audit
UQ
CIK
0000876378
Industry
Medical Devices & Instruments
Sector
Healthcare
NAICS
Surgical and Medical Instrument Manufacturing(339112)
CONTACT INFO
Address
1 TW Alexander Drive
Suite 160
Durham, NC 27703
Website
https://www.asensus.com
Facsimile
+1 919 765-8459
Telephone
+1 919 765-8400
Email
invest@transenterix.com
Kürzlich von Ihnen besucht
NYSE
ASXC
Asensus Su..
Register now
to watch these stocks streaming on the ADVFN Monitor.
Monitor lets you view up to 110 of your favourite stocks at once and is
completely free
to use.
Melden Sie sich bei ADVFN an
Jetzt registrieren
Der Markt LS (Lang&Schwarz) wird als Realtime Indikation kostenlos angezeigt und bietet Ihnen außerbörsliche Realtime Aktienkurse in der Zeit von Mo-Fr 08:00 bis 23:00, Samstags 10:00 bis 13:00 und Sonntags an.
NYSE und AMEX Kurse sind um mindestens 20 Minuten zeitverzögert.
Alle weiteren Kurse sind um mindestens 15 Minuten zeitverzögert, sofern nicht anders angegeben.
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende
Allgemeine Geschäftsbedingungen
Investitionen Warnung
Copyright © 1999 - 2022
Datenschutzrichtlinie
Zustimmungseinstellungen
ADVFN UK
Investors Hub
ADVFN Italy
ADVFN Australia
ADVFN Brazil
ADVFN Canada
ADVFN Germany
ADVFN Japan
ADVFN Mexico
ADVFN France
ADVFN US
P: V:de D:20220819 22:47:44
Login
Ihre Daten wurden nicht erkannt.
Bitte versuchen Sie es nochmal
Benutzername
Passwort
Passwort vergessen?
support@advfn.de
Haben Sie kein Konto?
Jetzt registrieren